Re: One More Promissory Note-Aug 9/24
|
7
|
Zenith Epigenetics
|
Aug 21, 2024 11:23AM
|
Re: Buy order for 10,000
|
7
|
Resverlogix Corp.
|
Dec 03, 2020 12:04PM
|
Re: Resverlogix Commences Dosing in Phase 3 Clinical Trial BETonMACE
|
7
|
Resverlogix Corp.
|
Nov 12, 2015 12:54PM
|
Bloomberg today, “Trump orders overhaul of long standing approach to kidney care”
|
7
|
Resverlogix Corp.
|
Jul 10, 2019 12:53PM
|
Re: ...is anybody out there at the AGM...?
|
7
|
Resverlogix Corp.
|
Sep 30, 2015 05:04PM
|
Re: Clovis' Rubracra
|
7
|
Zenith Epigenetics
|
Oct 05, 2018 12:12PM
|
Re: Missed CEO replacement opportunity: Dr. David Kideckel
|
7
|
Resverlogix Corp.
|
Aug 25, 2021 09:43PM
|
Re: Don's April 14th Interview on the Drive
|
7
|
Resverlogix Corp.
|
Apr 15, 2021 12:05PM
|
Re: Trillium
|
7
|
Zenith Epigenetics
|
Aug 25, 2021 10:23PM
|
Re: And we wait.......
|
7
|
Resverlogix Corp.
|
Jan 24, 2018 07:11AM
|
Re: Private placement
|
7
|
Resverlogix Corp.
|
Aug 30, 2018 12:30PM
|
Re: And we wait.......
|
7
|
Resverlogix Corp.
|
Jan 24, 2018 07:34AM
|
Re: Is the company trying to exasperate retail investors?
|
7
|
Resverlogix Corp.
|
Jun 30, 2017 11:37AM
|
Re: FDA busts Merck's Keytruda in triple-negative breast cancer with a CRL — not unexpected given its disastrous adcomm
|
7
|
Zenith Epigenetics
|
Mar 30, 2021 04:28PM
|
Re: We Must Start Planning For a Permanent Pandemic.
|
7
|
Resverlogix Corp.
|
Mar 28, 2021 04:53PM
|
Re: New Variant
|
7
|
Resverlogix Corp.
|
Nov 26, 2021 01:58PM
|
Long Covid
|
7
|
Resverlogix Corp.
|
Jan 18, 2024 09:07PM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
7
|
Resverlogix Corp.
|
Dec 15, 2021 05:25PM
|
Re: Zenith Epigentics and Resverlogix update 22 Jan 2018
|
7
|
Resverlogix Corp.
|
Jan 31, 2018 05:50PM
|
Re: My guess is a second BTD is coming
|
7
|
Resverlogix Corp.
|
Feb 08, 2020 02:50PM
|